Barclays Maintains Underweight on NOV, Raises Price Target to $14
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Barclays analyst David Anderson maintains NOV (NYSE:NOV) with a Underweight and raises the price target from $11 to $14.
Barclays analyst David Anderson maintains NOV (NYSE:NOV) with a Underweight and raises the price target from $11 to $14.